Shuang Wang

Shuang Wang

Auto-generated profile, based on publicly available information

Shuang Wang

Department of Hematology, The First Hospital of China Medical University, 110001 Shenyang, Liaoning, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2025 in Frontiers in Bioscience-Landmark
Verified
Journal Article
Open access
YGYixin Guo
Yixin Guo
SWShuang Wang
Shuang Wang
XHXinyue Huang
Xinyue Huang
YZYanhua Zheng
Yanhua Zheng
FLFang Liu
Fang Liu
XWXiaoxue Wang
Xiaoxue Wang
Single-cell RNA sequencing (scRNA-seq) technology, also known as single-cell transcriptome sequencing, has become a key tool in biology and medicine, enabling deeper insights into cellular diversity and disease mechanisms. Since 2009 when scRNA-seq technology was first introduced, many technologies have been developed and improved, with a wide range of applications in haematopoietic malignancies, solid tumours, and other fields. These technologies have been used by researchers to map transcriptomes, study intra- and inter-cellular heterogeneity, investigate tumour microenvironments, analyse specific cellular subpopulations, and assist in clinical studies. This review categorises scRNA-seq on the basis of different single-cell amplification techniques, provides an overview of the principles of currently commonly used scRNA-seq techniques, discusses the application of scRNA-seq in the context of haematopoietic malignancies, and will hopefully play a role in the future development of single-cell sequencing technologies.